Condition
Lichen Planus of Vulva
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05953090Not ApplicableRecruiting
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
NCT05330572Recruiting
Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
NCT03656666Phase 2UnknownPrimary
The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus
Showing all 3 trials